HeartWare to Present at J.P. Morgan Healthcare Conference in San Francisco

FRAMINGHAM, Mass. and SYDNEY, Jan. 6 /PRNewswire-FirstCall/ -- HeartWare International, Inc. (Nasdaq: HTWR, ASX: HIN), a leading innovator and provider of less invasive, miniaturized circulatory support technologies revolutionizing the treatment of advanced heart failure, today announced that it is scheduled to make an investor presentation at the 28th Annual J.P. Morgan Healthcare Conference at 3:00 pm PST on Wednesday, January 13. The conference will be held January 11-14 at the Westin St. Francis Hotel in San Francisco.

A live webcast of the Company's presentation at the conference will be available via a link provided at www.heartware.com. An archived replay of the presentation will also be available shortly after the presentation time for a period of 90 days.

About HeartWare International

HeartWare International develops and manufactures miniaturized implantable heart pumps, or left ventricular assist devices, to treat Class IIIb and Class IV patients suffering from advanced heart failure. The HeartWare® Ventricular Assist System features the HVAD(TM) pump, a small full-output circulatory support device (up to 10L/min flow) designed to be implanted next to the heart, avoiding the abdominal surgery generally required to implant competing devices. HeartWare has received CE Marking for the HeartWare® Ventricular Assist System in the European Union. The device is currently the subject of a 150-patient clinical trial in the United States for a Bridge-to-Transplant indication.


    For further information:
    ------------------------
    Christopher Taylor
    HeartWare, Inc.
    ctaylor@heartwareinc.com
    Tel: +1 508 739 0950

    Matt Clawson
    Allen & Caron Inc
    matt@allencaron.com
    Tel: +1 949 474 4300

SOURCE HeartWare International, Inc.

International News / Press Release source: PR Newswire
Copyright PR Newswire. All Rights Reserved.

International Business News / Press Releases

Newmont Reports 8% Increase in Equity Gold Reserves to 91.8 Million Ounces; Details 2010 Exploration Funding and Opportunities
PR Newswire

Mylan Reports Adjusted Diluted EPS of $0.33 for the Quarter and $1.30 for the Year Ended Dec. 31, 2009
PR Newswire

Newmont Reports Record Operating Cash Flow of $2.9 Billion and Adjusted Net Income(1) of $1.4 Billion ($2.79 per Share) in 2009
PR Newswire

IFQC Ranks Top 100 Countries by Gasoline Benzene Standards; South Korea Ranks First
PR Newswire

International Health News / Press Releases

Ginger Prices Could Skyrocket on H1N1 Fears
PR Newswire

Buchang Global Health Forum 2009: An Innovative Approach for Management of H1N1 Swine Flu
PR Newswire

Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India
PR Newswire

Milestone Scientific to Establish Joint Venture to Develop Medical Drug Delivery Instruments
PR Newswire

Tianyin Pharmaceutical Co., Inc. Provides Fiscal 2011 Guidance
PR Newswire

Suggested pages for your additional reading